Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.40 |
| ▸ | MC4R | P32245 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 3/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.37 |
| ▸ | HTR7 | P34969 | 3/20 | 0.35 |
| ▸ | FLT3 | P36888 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14069128 | 0.94 | MC4R (0.41) | GSRMC4RMCHR1TLR9HRH3 | |
| SCHEMBL4744753 | 0.89 | ACP1 (0.40) | GSRMC4RMCHR1HRH3KCNH2 | |
| SCHEMBL4748222 | 0.89 | HRH3 (0.47) | GSRMC4RMCHR1TLR9HRH3 | |
| SCHEMBL4747565 | 0.87 | GSR (0.48) | GSRTLR9HTR7 | |
| SCHEMBL4747148 | 0.86 | HRH3 (0.39) | MC4RTLR9HRH3 | |
| SCHEMBL4743800 | 0.84 | HRH3 (0.38) | MC4RHRH3 | |
| SCHEMBL4743769 | 0.83 | LCK (0.41) | GSRMC4RTLR9 | |
| SCHEMBL4748253 | 0.81 | GSR (0.48) | GSRMC4RHTR7 | |
| SCHEMBL4743737 | 0.76 | GSR (0.48) | GSRFLT3 | |
| SCHEMBL4744199 | 0.75 | KCNH2 (0.48) | GSRMC4RHRH3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008114009-A1 | 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CAMBRIDGE ENTERPRISE LTD. (GB) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008114009-A1 | 10H-BENZO(G)PTERDINE-2,4-DIONE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CAMBRIDGE ENTERPRISE LTD. (GB) | 2008-09-25 | — | — | WO | disclosed |